Category: pyridine-derivatives

Kolder, C. R.; den Hertog, H. J. published an article in 1953, the title of the article was Synthesis and reactivity of 5-chloro-2,4-dihydroxypyridine.HPLC of Formula: 861024-77-3 And the article contains the following content:

The synthesis of 5-chloro-2,4-dihydroxypyridine (I) is described. 4-Nitropyridine 1-oxide (II) (24 g.), prepared by known procedures was heated 6 hrs. at 110° (sealed tube) with 120 ml. SO2Cl2, giving 7 g. 2,4-dichloropyridine (III), b1.5 73-5°, and 5.5 g. recovered II. From heating the flask residue left from vacuum distillation of III with concentrated aqueous NH3 at 180° was obtained 1.5 g. 4-amino-2,3,5-trichloropyridine, m. 147-8°. III (12 g.) heated 5 hrs. at 170-80° (sealed tube) with 150 ml. aqueous NH3, 25 g. NaOH added, and the product extracted with Et2O gave 2 g. 2-amino-4-chloropyridine, m. 130-1°, and 6 g. 4-amino-2-chloropyridine (IV), m. 91-1.5°. IV (3 g.) heated 6 hrs. at 160° (sealed tube) with a solution of 1 g. Na in 15 ml. absolute EtOH gave 2 g. (60-5%) 4-amino-2-ethoxypyridine (V), m. 88-9°. V (0.4 g.) in 20 ml. saturated HCl treated dropwise with 0.25 g. NaNO2 in H2O in the cold gave 0.4 g. (85-90%) 4-chloro-2-ethoxypyridine (VI), m. -1 to + 1°; picrate, m. 130-1°. VI chlorinated in HOAc with Cl gas gave 75-80% 4,5-dichloro-2-ethoxypyridine (VII), m. 56-7°. VII (1 g.) heated 8 hrs. at 160° (sealed tube) with 1 g. NaOH in 20 ml. 50% aqueous EtOH gave 0.6 g. 5-chloro-2,4-diethoxypyridine (VIII), m. 56.5-57°, and 0.35-0.4 g. 5-chloro-2-ethoxy-4-hydroxypyridine, m. 201.5-2°. VIII (0.65 g.) heated 4 hrs. at 160° (sealed tube) with 20 ml. 25% aqueous HCl gave 0.47 g. (95-100%) I, m. 273-4° (decomposition) VII (0.1 g.) heated 4 hrs. at 160° (sealed tube) with 3 ml. 25% aqueous HCl gave 90-100% 4,5-dichloro-2-hydroxypyridine (IX), m. 231° (decomposition). IX heated with NaOEt solution as above gave 5-chloro-4-ethoxy-2-hydroxypyridine, m. 209.5-10.5°. IX heated 2.5 hrs. at 120-30° (sealed tube) with 3.5 ml. POCl3 gave 2,4,5-trichloropyridine (X), m. 8-9°. X heated with aqueous NH3 gave 4-amino-2,5-dichloropyridine, m. 125.5-26°; picrate, m. 164-5°. I heated with POCl3 gave X; POBr3 gave 2,4-dibromo-5-chloropyridine (XI), m. 61.5-2.5°. I heated with HCl or HBr at 250° gave only unchanged starting material but when heated in 48% aqueous HBr containing Br it gave 3-bromo-5-chloro-2,4-dihydroxypyridine (XII), m. 258-9° (decomposition), no depression with an authentic specimen. XII with POCl3 gave 3-bromo-2,4,5-trichloropyridine (XIII), m. 37-7.5°, and with POBr3 2,3,4-tribromo-5-chloropyridine (XIV), m. 77.5-8.5°. Mixed m.ps. of XI with the 3-Cl somer, of XIII with 5-bromo-2,3,4-trichloropyridine, and of XIV with 2,4,5-tribromo-3-chloropyridine all gave depressions indicating non-identity and serving as further evidence of the assigned structures. The experimental process involved the reaction of 2,4-Dibromo-3-chloropyridine(cas: 861024-77-3).HPLC of Formula: 861024-77-3

2,4-Dibromo-3-chloropyridine(cas:861024-77-3) belongs to pyridine-derivatives. Several pyridine derivatives play important roles in biological systems. While its biosynthesis is not fully understood, nicotinic acid (vitamin B3) occurs in some bacteria, fungi, and mammals.HPLC of Formula: 861024-77-3

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Takata, Toshihiro published an article in 1962, the title of the article was Synthesis of methylpyridine and 1,8-naphthyridine derivatives.Safety of 3-Methylpyridine-2,6-diamine And the article contains the following content:

When a mixture of 43 g. α,α’-dimethylglutaronitrile (I) and 30 g. NaNH2 in 258 ml. HCONH2 was kept for 2 days, filtered, and washed with PrOH and EtOAc, 41 g. α,α’-dimethylglutarimidine (II), m. 209-10° (decomposition) (absolute EtOH), was obtained. Similarly α-methylglutaronitrile gave 70% of α-methylglutarimidine (III), m. 154-5° (decomposition) (absolute EtOH). Reduction of 7 g. II in 100 ml. absolute EtOH was carried out with 98 g. Na and excess EtOH. Steam distillation of the product and evaporation of the acidified distillate and basification with NaOH gave 4.6 g. 3,5-dimethylpiperidine (IV), b. 144°, d20 0.8532, n20D 1.4560; picrate m. 184°. Reduction of III gave 3-methylpiperidine (V), b. 125-6°, d20 0.8570, n20D 1.4506; picrate m. 105°. Dehydrogenation of 0.5 g. IV with 0.2 g. of a Pd catalyst gave 0.35 g. 3,5-dimethylpyridine (VI), b. 168-71°, d20 0.9096, n20D 1.4501; picrate m. 242-3° (decomposition). 3-Methylpyridine (VII) was obtained similarly from V; picrate m. 149-50°. Dehydrogenation of 1 g. II in 4 ml. Ph2O at 300° for 11 hrs. with Pd catalyst gave 0.3 g. 2,6-diamino-3,5-dimethylpyridine (VIII), m. 186-7° (C6H6). VIII was acetylated with Ac2O in a sealed tube at 170° for 1 hr. to give the tetraacetyl derivative (IX), m. 149° (C6H6). Acetylation of VIII at 95° for 1 hr. gave the diacetyl derivative (X), m. 197°. 2,6-Diamino-3-methylpyridine (XI), m. 156-7°, was obtained in 30% yield by the dehydrogenation of III with Pd catalyst. Treatment of 12.2 g. VII with 16 g. NaNH2 in 16 g. Tetralin at 150-3° for 4 hrs. and at 198-200° for 17 hrs. and pouring the mixture into H2O and extraction with C6H6 and evaporation gave 2.5 g. XI. Acetylation of XI with Ac2O at 170-180° for 3 hrs. gave the triacetyl derivative, m. 142-4°. Acetylation of XI with Ac2O at 90-100° for 1 hr. gave the diacetyl derivative, m. 220-1°. Treatment of 2,4,6-tricyano-n-heptane (XII) with NaNH2 as before gave 3,6-dihydro-2,7-diiminooctahydro-1,8-naphthyridine (XIII), m. 222-4° (decomposition), in 87% yield and 1,3,5-tricyanohexane (XIV) gave 3-methyl-2,7-diiminooctahydro-1,8-naphthyridine (XV), m. 204-6° (decomposition), in 65% yield, while 1,3,5-tricyanopentane (XVI) gave 2,7-diiminooctahydro-1,8-naphthyridine (XVII) in 82% yield. A solution of 1.5 g. XIII in 240 ml. amyl alcohol was reduced with 21 g. Na at 130-40°. Working up as for IV gave 1 g. 3,6-dimethyldecahydro-1,8-naphthyridine (XVIII), m. 162-3° (C6H6); dipicrate m. 213° (decomposition). Similar reductions of 7 g. XV in 800 ml. amyl alcohol and 98 g. Na gave 4 g. 3-methyldecahydro-1,8-naphthyridine (XIX), m. 116-17° [dipicrate m. 205° (decomposition)] and of 1.2 g. XVII with 17 g. Na gave 0.9 g. decahydro-1,8-naphthyridine (XX), m. 116-17° (dipicrate m. 195°). Dehydrogenation of XVIII with a Pd catalyst in Ph2O gave 3,6-dimethyl-1,8-naphthyridine (XXI), m. 191-2° (petr. ether) in 71% yield; picrate m. 210-11° (decomposition). To a mixture of 320 g. CH2(CO2Et)2 (XXII) and 280 g. CH2:CMeCN was added a solution of 11 g. Na in 80 g. EtOH and the mixture stirred at 30-50° for 8 hrs. and at 80-90° for 2 hrs. Addition of HCl, and distillation of the product gave 338 g. α,α’-dimethyl-γ,-γ-dicarbethoxypimelonitrile (XXIII), b2 175°. γ,γ-Dicarbethoxypimeronitrile (XXIV), m. 60-2°, was obtained in 76% yield from 187 g. XXII, and 123 g. acrylonitrile and 10.6 ml. of 30% KOH in aqueous MeOH at room temperature for 2 hrs. XXIII (115 g.) was hydrolyzed with 55 g. KOH in 500 ml. absolute EtOH for a few days at room temperature Addition of water, acidification, and extraction with EtOAc gave α,α’-dimethyl-γ,γ-dicarboxypimelonitrile (XXV), m. 134-6° (decomposition). Similarly XXIV gave the corresponding diacid (XXVI), m. 158°. The K salt of XXV (47.1 g.) in 50% aqueous EtOH was treated with H at 100 atm. below 60° in the presence of 19 g. Raney Ni catalyst and the mixture was concentrated, acidified, and heated at 200° for 3 hrs. Addition of NaOEt in EtOH gave 20 g. 3-(β-methyl-ω-aminopropyl)-5-methyl-2-piperidone (XXVII); picrate m. 184-6°. Pyrolysis of 0.7 g. XXVII at 300° gave after purification as the hydrochloride and basification, 3,6-dimethyltetrahydro-1,8-naphthyridine (XXVIII), m. 110-11°; monopicrate m. 256°. Dehydrogenation of 0.11 g. XXVIII in 2 ml. Ph2O at 250-80° for 20 hrs. in the presence of Pd catalyst gave XXI. Reduction of XXVIII with Na in amyl alcohol gave XVIII. Reduction of 28 g. K salt of XXVI with Raney Ni as for XXV gave 13 g. 3-(ω-aminopropyl)-2-piperidone (XXIX); picrate m. 207°. Pyrolysis of XXIX gave hexahydro-1,8-naphthyridine; picrate m. 228-30°. The experimental process involved the reaction of 3-Methylpyridine-2,6-diamine(cas: 51566-22-4).Safety of 3-Methylpyridine-2,6-diamine

3-Methylpyridine-2,6-diamine(cas:51566-22-4) belongs to pyridine-derivatives. Several pyridine derivatives play important roles in biological systems. While its biosynthesis is not fully understood, nicotinic acid (vitamin B3) occurs in some bacteria, fungi, and mammals.Safety of 3-Methylpyridine-2,6-diamine

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

On January 11, 2018, Yamada, Kentaro; Satoh, Shigenobu; Hashizume, Hiroshi; Yoshimura, Noriko; Kagotani, Ryohei; Ishimoto, Yuyu; Abe, Yuichiro; Toyoda, Hiromitsu; Terai, Hidetomi; Masuda, Takeshi; Muraki, Shigeyuki; Nakamura, Hiroaki; Yoshida, Munehito published an article.Category: pyridine-derivatives The title of the article was Diffuse idiopathic skeletal hyperostosis is associated with lumbar spinal stenosis requiring surgery.. And the article contained the following:

Factors related to the onset and progression of lumbar spinal stenosis (LSS) have not yet been identified. Diffuse idiopathic skeletal hyperostosis (DISH) increases mechanical loading on the non-fused lumbar levels and may therefore lead to LSS. This cross-sectional study aimed to identify associations between LSS and DISH. This study included 2363 consecutive patients undergoing surgery for LSS and 787 general inhabitants without symptoms of LSS as participants of the population-based cohort study, Research on Osteoarthritis/Osteoporosis Against Disability. Standing whole-spine radiographs were used to diagnose DISH based on the criteria proposed by Resnick and Niwayama. The prevalence of DISH showed a significant step-wise increase among asymptomatic inhabitants without radiographic LSS, asymptomatic inhabitants with radiographic LSS, and patients with LSS requiring surgery (14.4, 21.1, and 31.7%, respectively; p < 0.001). The distribution of DISH was similar between the groups, but the lower thoracic and upper-middle lumbar spine regions were more frequently involved in patients with LSS requiring surgery. Multivariate analysis indicated that DISH was an independent associated factor for LSS requiring surgery (adjusted odds ratio 1.65; 95% confidence interval 1.32-2.07) after adjustment for age, sex, body mass index, and diabetes mellitus. Among patients with LSS requiring surgery, a higher occurrence of stenosis at the upper lumbar levels and multi-level stenosis were observed in patients with DISH requiring surgery than in patients without DISH. In conclusion, DISH is independently associated with LSS requiring surgery. The decrease in the lower mobile segments by DISH may increase the onset or severity of LSS. The experimental process involved the reaction of N,N-Dimethyl-3-phenyl-3-(pyridin-2-yl)propan-1-amine maleate(cas: 132-20-7).Category: pyridine-derivatives

The Article related to diffuse idiopathic skeletal hyperostosis, general inhabitants, lumbar spinal stenosis, prevalence, standing whole-spine radiographs, and other aspects.Category: pyridine-derivatives

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

On July 4, 2019, Maghsoudlou, Siavash; Beyene, Joseph; Yu, Zhijie Michael; McDonald, Sarah D published an article.SDS of cas: 132-20-7 The title of the article was Phenotypic Classification of preterm Birth Among Multiparous Women: A Population-Based Cohort Study.. And the article contained the following:

OBJECTIVE: The Global Alliance to Prevent Prematurity and Stillbirth developed a phenotypic classification for preterm birth using clinical presentation (rather than risk factors) to improve surveillance. The objective of this study was to determine distributions of preterm birth phenotypes and associations with Caesarean section, low Apgar score, and neonatal death in multiparous women, stratifying by first versus recurrent preterm births. METHODS: This population-based cohort study used the Better Outcomes Registry and Network (BORN) of multiparous women giving birth in hospital with a singleton after 20 weeks in Ontario from 2012 to 2014 (Canadian Task Force Classification II-2). RESULTS: In multiparous women with preterm birth, 29.6% had a history of recurrence, of whom 66.2% had at least one clinical condition associated with the phenotypic model, compared with 63.5% of first preterm births. In recurrent preterm births, criteria for maternal, fetal, and placental conditions were met in 44.5%, 37.9%, and 8.2%, respectively, compared with 36.8%, 39.0%, and 10.4%, respectively, of first preterm births. Associations of preterm birth with Caesarean section, low Apgar score, and neonatal death varied across clinical conditions but were similar between first and recurrent preterm births; for example, for recurrent preterm birth, Caesarean section for maternal, fetal, and placental conditions had odds ratios of 1.66 (95% confidence interval [CI] 1.32-2.07), 1.09 (95% CI 0.80-1.49), and 3.92 (95% CI 1.98-7.78), compared with first preterm birth odds ratios of 1.21 (95% CI 1.03-1.41), 0.92 (95% CI 0.77-1.10), and 6.24 (95% CI 4.07-9.56). CONCLUSION: This study provides novel evidence of the utility of the preterm birth phenotypic classification model by using stratification for previous preterm birth, a robust predictor-with variation in phenotypes in initial and recurrent preterm births. The experimental process involved the reaction of N,N-Dimethyl-3-phenyl-3-(pyridin-2-yl)propan-1-amine maleate(cas: 132-20-7).SDS of cas: 132-20-7

The Article related to preterm birth, prematurity, phenotyping, clinical presentations, risk factors, population-based, cohort study, and other aspects.SDS of cas: 132-20-7

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Prescott, Benjamin published an article in 1971, the title of the article was Protective effect of certain sulfonic acids on the toxicity of lucanthone.Safety of Pyridine-3-sulfonic acid And the article contains the following content:

Simultaneous oral administration of 6-thymolsulfonic acid (I) [96-68-4] (1.25 kg/kg) with a lethal dose of the schistosomacidal agent lucanthone (II) [479-50-5] (500 mg/kg) increased the survival time of treated mice. Of 6 sulfonic acid detoxifying agents tested, I was the most effective. The experimental process involved the reaction of Pyridine-3-sulfonic acid(cas: 636-73-7).Safety of Pyridine-3-sulfonic acid

The Article related to lucanthone toxicity thymolsulfonate, sulfonic acid lucanthone toxicity, schistosomacide lucanthone toxicity, and other aspects.Safety of Pyridine-3-sulfonic acid

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Getahun, Darios; Strickland, Daniel; Zeiger, Robert S; Fassett, Michael J; Chen, Wansu; Rhoads, George G; Jacobsen, Steven J published an article in 2010, the title of the article was Effect of chorioamnionitis on early childhood asthma..Quality Control of N,N-Dimethyl-3-phenyl-3-(pyridin-2-yl)propan-1-amine maleate And the article contains the following content:

OBJECTIVE: To examine the association between chorioamnionitis and childhood asthma based on gestational age at birth and race/ethnicity. DESIGN: A retrospective cohort study using the Kaiser Permanente Southern California (KPSC) Matched Perinatal records. SETTING: Kaiser Permanente Southern California, Pasadena, California. PARTICIPANTS: All singleton children born in KPSC hospitals between 1991 and 2007 (N = 510 216). MAIN EXPOSURE: Clinically diagnosed chorioamnionitis. MAIN OUTCOME MEASURES: Physician-diagnosed asthma in children aged 8 years or younger. RESULTS: The incidence rates of asthma among preterm- and full term-born children of pregnancies complicated by chorioamnionitis were 100.7 and 39.6 per 1000 person-years, respectively (incidence rate ratio, 2.9; 95% confidence interval [CI], 2.6-3.3). Children aged 8 years or younger with asthma were more likely to be born to women who were aged 35 years or older, African American, had 13 or more years of education, had maternal asthma, used antibiotics, had chorioamnionitis during the pregnancy, and had a male child. Multivariable Cox regression analysis revealed that children born at 23 to 28, 29 to 33, and 34 to 36 weeks’ gestation after pregnancies complicated by chorioamnionitis had a 1.23-fold (95% CI, 1.02-1.49), 1.51-fold (95% CI, 1.26-1.80), and 1.20-fold (95% CI, 1.03-1.47), respectively, increased risk of asthma compared with children of similar gestational age born after pregnancies not complicated by chorioamnionitis. A preterm pregnancy complicated by chorioamnionitis was associated with increased risk of asthma among white (hazard ratio [HR], 1.66; 95% CI, 1.32-2.07), African American (HR, 1.98; 95% CI, 1.60-2.44), and Hispanic (HR, 1.70; 95% CI, 1.45-2.00), but not Asian/Pacific Islander (HR, 1.15; 95% CI, 0.83-1.58) women. CONCLUSION: Findings suggest that chorioamnionitis at preterm gestation is independently associated with increased risk of childhood asthma. The experimental process involved the reaction of N,N-Dimethyl-3-phenyl-3-(pyridin-2-yl)propan-1-amine maleate(cas: 132-20-7).Quality Control of N,N-Dimethyl-3-phenyl-3-(pyridin-2-yl)propan-1-amine maleate

The Article related to asthma: epidemiology, child, child, preschool, chorioamnionitis: diagnosis, chorioamnionitis: epidemiology, cohort studies, ethnicity: statistics & numerical data, female, fetal diseases: epidemiology, fetal membranes, premature rupture, gestational age, health status, humans, infant, infant, newborn, male, maternal age, pregnancy and other aspects.Quality Control of N,N-Dimethyl-3-phenyl-3-(pyridin-2-yl)propan-1-amine maleate

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Riise, Øystein Rolandsen; Laake, Ida; Vestrheim, Didrik; Flem, Elmira; Moster, Dag; Riise Bergsaker, Marianne Adeleide; Storsæter, Jann published an article in 2017, the title of the article was Risk of Pertussis in Relation to Degree of Prematurity in Children Less Than 2 Years of Age..Electric Literature of 132-20-7 And the article contains the following content:

BACKGROUND: A few previous studies reported increased risk of pertussis in children with birth weight less than 2500 g. The risk of pertussis by degree of prematurity has not been determined in a cohort study. The vaccine effectiveness (VE) against reported pertussis in preterm infants is unknown. METHODS: Data were obtained from the Medical Birth Registry of Norway (1998-2010) and linked to other national registries. In total, 713,166 children were included in our study and followed until 2 years of age. Incidence rate ratios (IRRs) and confidence intervals (CIs) were estimated with Poisson regression. RESULTS: We identified 999 reported cases of pertussis. We observed a higher rate of reported pertussis in preterm than in full-term infants, IRR = 1.65 (95% CI: 1.32-2.07). Compared to full-term infants, the risk of reported pertussis in infants born at gestational age (GA) 35-36, 32-34 and 23-27 weeks were higher [IRRs = 1.49 (95% CI: 1.11-2.01), 1.63 (95% CI: 1.06-2.51) and 4.49 (95% CI: 2.33-8.67), respectively]. Moreover, preterm infants had a higher rate of pertussis-related hospitalization than full-term infants [IRR = 1.99 (95% CI: 1.47-2.71)]. The VE against reported pertussis for the third dose was 88.8% (95% CI: 84.3-92.0) in full-term infants and 93.0% (95% CI: 85.8-96.5) in preterm infants. CONCLUSIONS: In this cohort study, preterm infants including those born at GA 35 and 36 weeks had increased risk of reported pertussis. The VE was similar in preterm and full-term infants. The experimental process involved the reaction of N,N-Dimethyl-3-phenyl-3-(pyridin-2-yl)propan-1-amine maleate(cas: 132-20-7).Electric Literature of 132-20-7

The Article related to birth weight, child, preschool, cohort studies, female, gestational age, hospitalization: statistics & numerical data, humans, infant, infant, low birth weight, infant, newborn, infant, premature: immunology, male, norway, pertussis vaccine: administration & dosage, registries, risk, vaccine potency, whooping cough: diagnosis and other aspects.Electric Literature of 132-20-7

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

On June 20, 2019, Kaess, Bernhard M; Andersson, Charlotte; Duncan, Meredith S; Larson, Martin G; Aasbjerg, Kristian; Gislason, Gunnar H; Torp-Pedersen, Christian; Vasan, Ramachandran S published an article.Formula: C20H24N2O4 The title of the article was Familial Clustering of Cardiac Conduction Defects and Pacemaker Insertion.. And the article contained the following:

BACKGROUND: The etiopathogenesis of electrocardiographic bundle branch and atrioventricular blocks is not fully understood. We investigated familial clustering of cardiac conduction defects and pacemaker insertion in the FHS (Framingham Heart Study). Additionally, we assessed familial clustering of pacemaker insertion in the Danish general population. METHODS: In FHS, we used multivariable-adjusted logistic regression models to investigate the association of parental atrioventricular block (PR interval, ≥0.2 s), complete bundle branch block (QRS, ≥0.12 s), or pacemaker insertion with the occurrence of cardiac conduction abnormalities in their offspring. The Danish nationwide administrative registries were interrogated to assess the relations of parental pacemaker insertion with offspring pacemaker insertion. RESULTS: In FHS (n=371 cases with first-degree atrioventricular block, complete bundle branch block, or pacemaker insertion, and 1471 age- and sex-matched controls), individuals with at least 1 affected parent with a conduction defect had a 1.65-fold odds (odds ratio, 95% CI, 1.32-2.07) for manifesting an atrioventricular block and a 1.62-fold odds (95% CI, 1.08-2.42) for developing a complete bundle branch block. If at least 1 parent had any electrocardiographic conduction defect or pacemaker insertion, the offspring had a 1.62-fold odds (95% CI, 1.31-2.00) for experiencing any of these conditions. In Denmark (n=2 824 199 individuals; 5397 incident pacemaker implantations), individuals with at least 1 first-degree relative with history of pacemaker insertion had a multivariable-adjusted 1.68-fold (incidence rate ratio, 95% CI, 1.49-1.89) risk of undergoing a pacemaker insertion. If the affected relative was ≤45 years of age, the incidence rate ratio was markedly increased to 51.0 (95% CI, 32.7-79.9). CONCLUSIONS: Cardiac conduction blocks and risk for pacemaker insertion cluster within families. A family history of conduction system disturbance or pacemaker insertion should trigger increased awareness of a similar propensity in other family members, especially so when the conduction system disease occurs at a younger age. The experimental process involved the reaction of N,N-Dimethyl-3-phenyl-3-(pyridin-2-yl)propan-1-amine maleate(cas: 132-20-7).Formula: C20H24N2O4

The Article related to action potentials, adult, atrioventricular block: genetics, atrioventricular block: physiopathology, atrioventricular block: therapy, bundle-branch block: genetics, bundle-branch block: physiopathology, bundle-branch block: therapy, cardiac conduction system disease: diagnosis, cardiac conduction system disease: genetics and other aspects.Formula: C20H24N2O4

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

On June 1, 2016, Batsis, J A; Germain, C M; Vásquez, E; Bartels, S J published an article.Formula: C20H24N2O4 The title of the article was Prevalence of weakness and its relationship with limitations based on the Foundations for the National Institutes for Health project: data from the Health and Retirement Study.. And the article contained the following:

BACKGROUND/OBJECTIVES: The objectives of this study were to determine the prevalence of muscle weakness using the two 2014 Foundation for the National Institutes of Health (FNIH) Sarcopenia Project criteria and its relationship with physical limitations, basic activities of daily living (ADL) and instrumental ADL. SUBJECTS/METHODS: We performed a cross-sectional analysis of community-dwelling adults from the Health and Retirement Study 2006-2008 and identified a subsample of 5092 adults aged ⩾60 years with grip strength (GS) data. Self-reported physical limitations, basic ADL and instrumental ADL were assessed. Criteria for GS (men<26 kg; women <16 kg) and GS adjusted for body mass index (GS/BMI; men <1.0; women <0.56) were applied to the sample. We determined the prevalence of muscle weakness in each sex. Multivariable logistic regression was used to calculate the association of physical limitations, basic ADL and instrument ADL with weakness definitions in each sex. RESULTS: Mean age was 72.1 years (54.9% female). Mean GS was 38.3 and 22.9 kg and mean BMI was 29 kg/m2, respectively, in men and women. Weakness prevalence using GS and GS:BMI definitions were 7.8 and 15.2 (P<0.001), respectively, in men and 11.4 and 13.3% (P=0.04) in women. Overall prevalence of physical limitations, basic ADL limitations and instrumental ADL limitations was 52.9, 28.1 and 35.9%, respectively. In those with weakness, prevalence of physical limitations, basic ADL and instrumental ADL was 78.5, 42.3 and 65.3%, respectively, using the GS definition, and 79.7, 40.7 and 58.8%, respectively, using the GS/BMI definition. GS and the GS/BMI definitions of weakness were strongly associated with physical limitations (odds ratio (OR) 2.19 (95% confidence interval (CI): (1.67-2.87)) and 2.52 (2.01-3.17)), basic ADL (OR 1.59 (1.22-2.07) and 1.66 (1.32-2.07)) and instrumental ADLs (OR 1.98 (1.28-2.54) and 1.78 (1.44-2.20)). CONCLUSIONS: The new FNIH guidelines for weakness are associated with higher prevalence of physical limitations, basic ADL impairments and instrumental ADL impairments as compared with individuals without weakness. The experimental process involved the reaction of N,N-Dimethyl-3-phenyl-3-(pyridin-2-yl)propan-1-amine maleate(cas: 132-20-7).Formula: C20H24N2O4

The Article related to activities of daily living, aged, aging, cross-sectional studies, databases, factual, female, humans, male, middle aged, muscle weakness: epidemiology, muscle weakness: physiopathology, national institutes of health (u.s.), retirement, sarcopenia: epidemiology, sarcopenia: physiopathology, surveys and questionnaires and other aspects.Formula: C20H24N2O4

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

On August 12, 2020, Portelli Tremont, Jaclyn N; Orleans, Brian; Strassle, Paula D; Dreesen, Elizabeth B; Brownstein, Michelle R published an article.Related Products of 132-20-7 The title of the article was Hypertension in the Young Adult Trauma Population: Rethinking the Traditional “Incidentaloma”.. And the article contained the following:

BACKGROUND: Hypertension (HTN) is a treatable and preventable risk factor for cardiovascular disease that is often overlooked in young adults. As a result, young patients with HTN may enter the health care system as a trauma without a preexisting diagnosis. The potential impact of HTN (diagnosed and undiagnosed) on trauma outcomes is not known. MATERIALS AND METHODS: Patients aged 18-39 y from the 2013-2017 North Carolina Trauma Registry were included. Patients were stratified as having no HTN, previously diagnosed HTN (PD-HTN), or newly diagnosed HTN (ND-HTN) during a trauma admission. Multivariable logistic and linear regression compared inpatient outcomes between patients with and without HTN, as well as ND-HTN and PD-HTN. RESULTS: Six percent of trauma patients were diagnosed with HTN (n = 1906; 14% ND-HTN). Those with HTN were more likely to have an inpatient complication (odds ratio [OR]: 1.65, 95% confidence interval [CI]: 1.32-2.07) and intensive care unit stay (OR: 1.28, 95% CI: 1.12-1.46) compared with patients without HTN. Compared with PD-HTN, those with ND-HTN were more likely to present with extreme injury. In addition, patients with ND-HTN had higher odds of inpatient complications (OR: 1.95, 95% CI: 1.18-3.22) and 30-d readmission (OR: 2.00, 95% CI: 0.95-4.20) after accounting for demographics and injury severity. CONCLUSIONS: More than 10% of young adult trauma patients with HTN are not diagnosed before admission. HTN appears to have a detrimental impact on patient outcomes, with newly diagnosed patients having the worst outcomes. Trauma may serve as an opportunity for the diagnosis and treatment of HTN in young adults. Future studies should assess the impact of intervention on trauma outcomes. The experimental process involved the reaction of N,N-Dimethyl-3-phenyl-3-(pyridin-2-yl)propan-1-amine maleate(cas: 132-20-7).Related Products of 132-20-7

The Article related to adolescent, adult, comorbidity, female, hospital mortality, humans, hypertension: diagnosis, hypertension: epidemiology, incidental findings, intensive care units: statistics & numerical data, male, north carolina: geographic, north carolina: epidemiology, odds ratio, patient readmission: statistics & numerical data and other aspects.Related Products of 132-20-7

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem